CAS 127-07-1
:Hydroxyurea
- 1-Hydroxyurea
- Amino(Oxido-Λ5-Azanyl)Methanone
- Biosupressin
- Carbamohydroxamic acid
- Carbamohydroximic acid
- Carbamoyl oxime
- Carbamyl hydroxamate
- Cytodrox
- Droxia
- HU
- Hidrix
- Hidroxicarbamida
- Hydrea
- Hydreia
- Hydrixycarbamide
- Hydroxy Urea (D4)
- Hydroxy urea
- Hydroxycarbamid
- Hydroxycarbamide
- Hydroxycarbamine
- Hydroxylamine, N-(aminocarbonyl)-
- Hydroxylurea
- Hydura
- Hydurea
- Litaler
- Litalir
- Mylocel
- N-(aminocarbonyl)hydroxylamine
- N-Carbamoylhydroxylamine
- N-Hydroxyharnstoff
- N-Hydroxyurea
- Nci C04831
- Nsc 32065
- Onco-carbide
- Oxyrea
- Oxyurea
- Siklos
- Sk 22591
- Sq 1089
- Urea, N-hydroxy-
- Urea, hydroxy-
- Wr 83799
- Xromi
- hydroxyharnstoff
- carbamylhydroxamate
- Carbamoylhydroxylamine
- carbamohydroxyamicacid
- carbamohydroxamicacid
- hydroxy-ure
- HYDROXYUREA
- carbamoyloxime
- Weitere Synonyme anzeigen
Hydroxyurea
CAS:Formel:CH4N2O2Reinheit:>97.0%(HPLC)(N)Farbe und Form:White to Almost white powder to crystalMolekulargewicht:76.06Hydroxyurea, 98%
CAS:Hydroxyurea is used as an inhibitor of DNA synthesis and an anti-cancer drug. It is used as a precursor to prepare 1-hydroxy-5,6-dimethyl-1H-pyrimidine-2,4-dione via reaction with 2-methyl-3-oxo-butyric acid ethyl ester. It is used in the treatment of melanoma, resistant chronic myelocytic leukemia
Formel:CH4N2O2Reinheit:98%Farbe und Form:White to cream or yellow, Crystals or powder or crystalline powderMolekulargewicht:76.06HYDROXYCARBAMIDE CRS
CAS:HYDROXYCARBAMIDE CRSFormel:CH4N2O2Farbe und Form:Crystalline Powder. White. Powder.Molekulargewicht:76.0547Hydroxycarbamide
CAS:HydroxycarbamideFormel:CH4N2O2Reinheit:99.6%Farbe und Form:Off-WhiteMolekulargewicht:76.02728Hydroxyurea
CAS:Non-aromatic organic derivatives of hydrazine or of hydroxylamine for use as drugsFormel:CH4N2O2Farbe und Form:White Off-White PowderMolekulargewicht:76.06 g/molHydroxyurea
CAS:Hydroxyurea (Hydroxycarbamide), an antineoplastic agent, inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.Formel:CH4N2O2Reinheit:99.85% - 99.92%Farbe und Form:SolidMolekulargewicht:76.05Hydroxyurea
CAS:Formel:CH4N2O2Reinheit:98.0 - 102.0 % (anhydrous basis)Farbe und Form:White to off-white powderMolekulargewicht:76.06Hydroxyurea
CAS:HydroxyureaFormel:CH4N2O2Reinheit:98%Farbe und Form: white solidMolekulargewicht:76.05g/molHydroxy Urea
CAS:Kontrolliertes ProduktStability Hygroscopic
Applications An anti-neoplastic - inhibits ribonucleoside reductase and DNA replication. A potential therapy for sickle cell anemia which involves the nitrosylation of sickle cell hemoglobin. Horseradish peroxidase catalyzes nitric oxide formation from hydroxyurea in the presence of hydrogen peroxide.
References Ratcliffe, W., et al.: Lancet, 339, 164 (1992), Roodman, G., et al.: Cancer, 80, 1557 (1997), Horwitz, M., et al.: J. Clin. Endocrinol. Metab., 2003, 88, 1603 (2003),Formel:CH4N2O2Farbe und Form:White SolidMolekulargewicht:76.05Hydroxyurea
CAS:Hydroxyurea is a prodrug that is activated by the enzyme Jak2, which is found in the mitochondria of cells. Hydroxyurea is used to treat various types of cancer and other diseases, such as sickle cell anemia. It has been shown to be effective in inhibiting the growth of squamous cell carcinomas and myeloid leukemia cells. Hydroxyurea has also been shown to have synergistic effects when combined with other pharmacological agents, such as hydroxycarbamide and cytosine arabinoside. Hydroxyurea inhibits the production of energy in the form of ATP, which leads to death by apoptosis or necrosis. This drug also has inhibitory properties against bacterial infections, especially those caused by Mycobacterium tuberculosis and Mycobacterium avium complex.Formel:CH4N2O2Reinheit:Min. 97.5 Area-%Farbe und Form:White Off-White PowderMolekulargewicht:76.06 g/molHydroxyurea
CAS:Formel:CH4N2O2Reinheit:98%Farbe und Form:Solid, White crystalline powderMolekulargewicht:76.055














